(18)F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review

In the last years, (18)F-fluorodeoxyglucose PET/computed tomography ((18)F-FDG PET/CT) has demonstrated its utility for the evaluation of gastric cancer; however, considering some histotypes such as gastric signet ring cell carcinoma (GSRCC) the results are limited. The aim of this review is to analyze the diagnostic performance of (18)F-FDG PET and PET/CT for the assessment of GSRCC. METHODS: A wide literature search of the PubMed/MEDLINE, Scopus, Embase and Cochrane library databases was made to find relevant published articles about the diagnostic performance of (18)F-FDG PET or PET/CT for the evaluation of GSRCC. RESULTS: The comprehensive computer literature search revealed 179 articles. On reviewing the titles and abstracts, 162 articles were excluded because the reported data were not within the field of interest. Nine studies were included in the review and references were also screened for additional articles. Finally, 26 articles were selected and retrieved in full-text version. CONCLUSION: Despite some limitations affect our review, GSRCC seems to have low (18)F-FDG uptake, and therefore (18)F-FDG PET or PET/CT reveals impaired sensitivity for its evaluation. However, a correlation between (18)F-FDG uptake and some clinico-pathologic features (such as stage, depth of invasion, size and presence of nodal metastasis) has been demonstrated. Besides, a possible prognostic role of PET/CT features is starting to emerge.